Literature DB >> 22322197

The movement of self-assembled amphiphilic polymeric nanoparticles in the vitreous and retina after intravitreal injection.

Heebeom Koo1, Hyungwon Moon, Hyounkoo Han, Jin Hee Na, Myung Sook Huh, Jae Hyung Park, Se Joon Woo, Kyu Hyung Park, Ick Chan Kwon, Kwangmeyung Kim, Hyuncheol Kim.   

Abstract

The purpose of this study is to determine the correlation between the distribution of nanoparticles in the vitreous and retina and their surface properties after intravitreal injection. For this purpose, we synthesized seven kinds of nanoparticles through self-assembly of amphiphilic polymer conjugates in aqueous condition. They showed similar size but different surface properties. They were labeled with fluorescent dyes for efficient tracking. After intravitreal injection of these nanoparticles into a rodent eye, their time-dependent distribution in the vitreous and retina was determined in stacking tissue images by confocal microscopy. The results demonstrated that the surface property of nanoparticles is a key factor in determining their distribution in the vitreous and retina after intravitreal injection. In addition, immunohistochemistry and TEM images of retina tissues suggested the important mechanism related with Mülller cells for intravitreally administered nanoparticles to overcome the physical barrier of inner limiting membrane and to penetrate into the deeper retinal structures. Therefore, we expect that this study can provide valuable information for biomedical researchers to develop optimized nanoparticles as drug or gene carriers for retinal and optic nerve disorders such as glaucoma, age-related macular degeneration, and diabetic retinopathy. Copyright Â
© 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22322197     DOI: 10.1016/j.biomaterials.2012.01.030

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  38 in total

Review 1.  Challenges and opportunities for drug delivery to the posterior of the eye.

Authors:  Fernando J Cabrera; Daniel C Wang; Kartik Reddy; Ghanashyam Acharya; Crystal S Shin
Journal:  Drug Discov Today       Date:  2019-06-05       Impact factor: 7.851

Review 2.  Drug and gene delivery to the back of the eye: from bench to bedside.

Authors:  Cheryl L Rowe-Rendleman; Shelley A Durazo; Uday B Kompella; Kay D Rittenhouse; Adriana Di Polo; Alan L Weiner; Hans E Grossniklaus; Muna I Naash; Alfred S Lewin; Alan Horsager; Henry F Edelhauser
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-28       Impact factor: 4.799

3.  Photoreceptor-targeted gene delivery using intravitreally administered AAV vectors in dogs.

Authors:  R F Boyd; D G Sledge; S L Boye; S E Boye; W W Hauswirth; A M Komáromy; S M Petersen-Jones; J T Bartoe
Journal:  Gene Ther       Date:  2015-10-15       Impact factor: 5.250

Review 4.  Nanotechnology in retinal drug delivery.

Authors:  Sibo Jiang; Yesenia L Franco; Yan Zhou; Jianjun Chen
Journal:  Int J Ophthalmol       Date:  2018-06-18       Impact factor: 1.779

5.  Ocular drug delivery systems: An overview.

Authors:  Ashaben Patel; Kishore Cholkar; Vibhuti Agrahari; Ashim K Mitra
Journal:  World J Pharmacol       Date:  2013

6.  Micelle formulation of hexadecyloxypropyl-cidofovir (HDP-CDV) as an intravitreal long-lasting delivery system.

Authors:  Feiyan Ma; Kaihui Nan; SuNa Lee; James R Beadle; Huiyuan Hou; William R Freeman; Karl Y Hostetler; Lingyun Cheng
Journal:  Eur J Pharm Biopharm       Date:  2014-12-13       Impact factor: 5.571

Review 7.  Lipid-based drug delivery systems in the treatment of wet age-related macular degeneration.

Authors:  Joanne D Du; Wye-Khay Fong; Suzanne Caliph; Ben J Boyd
Journal:  Drug Deliv Transl Res       Date:  2016-12       Impact factor: 4.617

8.  Nanoparticle diffusion in, and microrheology of, the bovine vitreous ex vivo.

Authors:  Qingguo Xu; Nicholas J Boylan; Jung Soo Suk; Ying-Ying Wang; Elizabeth A Nance; Jeh-Chang Yang; Peter J McDonnell; Richard A Cone; Elia J Duh; Justin Hanes
Journal:  J Control Release       Date:  2013-01-28       Impact factor: 9.776

9.  Inflammatory response to intravitreal injection of gold nanorods.

Authors:  Michelle Gabriele Sandrian; Gadi Wollstein; Joel S Schuman; Richard A Bilonick; Yun Ling; Hiroshi Ishikawa; Larry Kagemann; Kyle C McKenna
Journal:  Br J Ophthalmol       Date:  2012-10-19       Impact factor: 4.638

10.  RES-loaded pegylated CS NPs: for efficient ocular delivery.

Authors:  Saravanakumar Pandian; Vinoth Jeevanesan; Chandrasekar Ponnusamy; Subramanian Natesan
Journal:  IET Nanobiotechnol       Date:  2017-02       Impact factor: 1.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.